Venous thromboembolism (VTE) is a common cause of morbidity and mortality among
patients with multiple myeloma (MM). The International Myeloma Working Group (IMWG) …

Aims The identification of venous thromboembolism (VTE) using administrative databases is
frequently required for reporting and research. The accuracy of International Classification of …

Importance Testosterone therapy is increasingly prescribed in patients without a diagnosis
of hypogonadism. This therapy may be associated with increased risk of venous …

Background Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia
mediated by IgM autoantibodies that trigger hemolysis via classical complement pathway …

Background: The benefit-risk profile of direct oral anticoagulants (DOACs) compared with
warfarin, and between DOACs in patients with atrial fibrillation (AF) and chronic liver disease …

A concerning increase in mortality from acute pulmonary embolism (PE) in young adults in
the United States has been reported. We extracted PE-related mortality rates (number of …

Abstract Background Direct oral anticoagulants (DOACs), namely rivaroxaban, apixaban,
dabigatran, and edoxaban, are now included together with warfarin as standards of care for …

Abstract Venous thromboembolism (VTE) affects 1.2 million people per year in the United
States. With several clinical changes in diagnosis and treatment approaches in the past …

Objective To determine the safety of direct oral anticoagulant (DOAC) use compared with
warfarin use for the treatment of venous thromboembolism. Design Retrospective matched …

Background Patients with decompensated cirrhosis are excluded or underrepresented in
clinical trials of systemic therapies for hepatocellular carcinoma (HCC) and comparisons of …